Controlling cytokine signaling by constitutive inhibitors.
about
Nitric oxide and peroxynitrite in health and diseaseOverexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivationExpression of suppressors of cytokine signaling-3 in Helicobacter pylori-infected rat gastric mucosal RGM-1cellsGenotoxicity and molecular response of silver nanoparticle (NP)-based hydrogelNarrative-based computational modelling of the Gp130/JAK/STAT signalling pathway.The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3.Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytesThe adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.Morphine suppresses IFN signaling pathway and enhances AIDS virus infection.Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaDecorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissueProtein inhibitor of activated STAT3 expression in lung cancer.Tumor necrosis factor superfamily in innate immunity and inflammation.Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxelInhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling.Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoproteinEpigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemiaRole of cytokines in head and neck squamous cell carcinoma.Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006.The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.STAT nuclear translocation: potential for pharmacological intervention.Hematopoietic cytokine receptor signaling.Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomasToxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses.The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitisThe association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.Challenges in clinical design of immunotherapy trials for malignant glioma.SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo.Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.Inhibition of interferon-α-induced signaling by hyperosmolarity and hydrophobic bile acids.Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.Suppressors of cytokine signaling abrogate diabetic nephropathy.SOCS-3 Regulates Alveolar Bone Loss in Experimental Periodontitis.Modulation of inducible nitric oxide synthase expression by sumoylation.
P2860
Q24645400-746D1A32-E90B-40F4-ABCB-1A89FDD972A8Q24678516-3B6A93F8-0C86-48A0-8A90-FFE751471857Q28565435-0AE85097-856E-4401-9F2A-E27FD1DFBF6BQ28728176-C7391B55-AC3E-441A-8662-86789057CA7FQ33430520-671110E5-0FCA-41DF-ADC9-57CA3BF026B0Q33589279-220AA00C-81A1-4FCC-8D52-4B973099EED2Q33634642-1A8D039D-C636-4184-AFFD-7B2C06F52D0AQ33897894-E2C1FB60-4919-4676-8B4F-5AAE9DE2419BQ33977596-0E5093E3-0DBE-4DF4-9D30-0230EF55DAB6Q34070358-0DD61F96-6F5E-4921-B0A4-9D9DA1B845ECQ34168153-E0BAF6D7-CF86-48B9-950A-E57B9F612714Q34258650-023001D0-BA03-4928-A59B-C2F3DCF1EC40Q34369823-C6A352C6-9A7A-4544-AD2D-63E627675019Q34754640-8B884CC8-5B7F-436D-BBB0-D3BB59154415Q35013622-AF51348A-735B-4F6B-A1CC-7C11EE609D8FQ35245316-F955FF07-FC8F-4A68-B907-DD306CDD1297Q35742549-AE3F4DA8-8EF7-4808-BCCB-944FC0732DEBQ35893359-812F82B3-2F77-40E0-80D0-3FB5029447C6Q35990647-13CBD312-21BC-46A8-8273-DE367EF34063Q36238674-CF224F02-DBA1-46B0-96E5-327C5644426DQ36613975-8A888DBC-F048-445A-93FA-F674B2254A08Q36739682-C948CB2D-0E9A-4B96-A885-15F2ACA41D43Q36836455-27F1D786-28E6-4560-9086-3C1B19759E77Q36956743-088CC1E4-5252-4E5E-8182-6B74628CBEADQ36970188-7E9961E8-0875-4756-A5D0-263C27014B58Q36992256-5DBCBCE0-71ED-4FBB-BBF9-8948063CC2ECQ37174303-B60404CA-D79F-42DE-BD7D-B178FB2BC46BQ37197979-E3D833B2-850A-46DA-AA07-6705F40E40C1Q37286029-8A222478-54EC-4CE7-B429-2B50EB288567Q37438034-D870E4FF-D9AF-4E10-A027-0E275F991BD7Q37608884-B018451B-C5E8-4006-B34F-7BF9BA7459B4Q37640613-74B405A8-6A3D-4B00-88A6-05E8CB4BCC0FQ39089939-686DD970-5CFE-4E80-8DB6-2179FA75C5FAQ39552807-DD791483-CC7C-4B64-A5C9-C9828C6AEB8AQ39579469-BFAEA1FC-B913-49FB-A335-FE2D5124FB64Q39638816-30160AA0-5429-4205-9847-C960ACF194ECQ39643717-64F8FBD2-D8E7-4090-A1ED-8D57DF96CA27Q39735007-DC16B3E5-9F91-439A-AF27-8B6CF38A5F94Q39812114-603470E7-787B-41EB-930C-5AFFAD59E0D3Q41962082-4893CC60-24F7-41AA-B865-5C2CF61C265A
P2860
Controlling cytokine signaling by constitutive inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Controlling cytokine signaling by constitutive inhibitors.
@ast
Controlling cytokine signaling by constitutive inhibitors.
@en
type
label
Controlling cytokine signaling by constitutive inhibitors.
@ast
Controlling cytokine signaling by constitutive inhibitors.
@en
prefLabel
Controlling cytokine signaling by constitutive inhibitors.
@ast
Controlling cytokine signaling by constitutive inhibitors.
@en
P1476
Controlling cytokine signaling by constitutive inhibitors.
@en
P2093
Devendra K Agrawal
Kriti Rakesh
P304
P356
10.1016/J.BCP.2005.04.042
P407
P577
2005-09-01T00:00:00Z